News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael J. Fine, MD

Articles by Michael J. Fine, MD

Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis

ByRobert Zivadinov, MD, PhD,Michael J. Fine, MD,Krishna R. Patel, PharmD, RPh,Neil Minkoff, MD

January 25th 2022

Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscanâ„¢)

ByJeffrey L. Cummings, MD, ScD,Michael J. Fine, MD,Igor D. Grachev, MD, PhD,C. Rick Jarecke, PharmD,Meridith K. Johnson, MSc,Phillip H. Kuo, MD, PhD,Joyce A. Oberdorf,Michael Rezak, MD, PhD,Da

March 24th 2014

Cost of Care for Malignant and Benign Renal Masses

ByAviva G. Asnis-Alibozek, PA-C,Michael J. Fine, MD,Paul Russo, MD,Trent McLaughlin, BSc(Pharm), PhD,Eileen M. Farrelly, MPH,Norman LaFrance, MD,William Lowrance, MD, MPH

August 12th 2013

Methods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access